Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Is Amgen Really as Cheap as It Looks?

TheMotleyFool

0 0

Is Amgen Really as Cheap as It Looks?Photo, wide shot, wide-angle lens, Mental health care service, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ce3b930-5e2a-4215-b686-0ad0eb0b922a.png

You might have run across headlines in recent months about how Amgen (NASDAQ: AMGN) is too cheap of a stock to ignore. I've seen several articles that trumpeted the big biotech's attractive valuation.

If you look at Amgen's forward price-to-earnings (P/E) ratio of 12.4, the stock indeed does appear to be trading at an appealing valuation. But is Amgen really as cheap as it looks? I don't think so.

Image source: Getty Images.

Source Fool.com

Like: 0

AMGN

Teilen